The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Role of a p53 polymorphism in the development of human papilloma-virus-associated cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J., & Howley, P. M. (1990) · Cell · doi:10.1016/0092-8674(90)90409-8 · Cited by 3,995
The human papilloma virus-16 E7-oncoprotein is able to bind to the retinoblastoma gene product
Dyson, N., Howley, P. M., Münger, K., & Harlow, E. (1989) · Science · doi:10.1126/science.2537532 · Cited by 3,017
Association of Human Papillomavirus Types 16 and 18 E6 Proteins with p53
Werness, B. A., Levine, A. J., & Howley, P. M. (1990) · Science · doi:10.1126/science.2157286 · Cited by 2,562
Rock, K. L., Gramm, C., Rothstein, L., Clark, K., Stein, R., Dick, L., Hwang, D., & Goldberg, A. L. (1994) · Cell · doi:10.1016/s0092-8674(94)90462-6 · Cited by 2,524
Vogelstein, B. (1992) · Cell · doi:10.1016/0092-8674(92)90421-8 · Cited by 1,862
Fenteany, G., Standaert, R. F., Lane, W. S., Choi, S., Corey, E. J., & Schreiber, S. L. (1995) · Science · doi:10.1126/science.7732382 · Cited by 1,583
THE UBIQUITIN SYSTEM FOR PROTEIN DEGRADATION
Hershko, A., & Ciechanover, A. (1992) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.61.070192.003553 · Cited by 1,410
Structural basis for the binding of proline-rich peptides to SH3 domains
Yu, H., Chen, J. K., Feng, S., Dalgarno, D. C., Brauer, A. W., & Schrelber, S. L. (1994) · Cell · doi:10.1016/0092-8674(94)90367-0 · Cited by 1,001
The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines.
Scheffner, M., Münger, K., Byrne, J. C., & Howley, P. M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.13.5523 · Cited by 849
Milner, J., & Medcalf, E. A. (1991) · Cell · doi:10.1016/0092-8674(91)90384-b · Cited by 612
Chittenden, T., Flemington, C., Houghton, A. B., Ebb, R. G., Gallo, G. J., Elangovan, B., Chinnadurai, G., & Lutz, R. J. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00246.x · Cited by 497
Primary structure polymorphism at amino acid residue 72 of human p53.
Matlashewski, G. J., Tuck, S., Pim, D., Lamb, P., Schneider, J., & Crawford, L. V. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.2.961 · Cited by 497
Self-citationBANKS, L., MATLASHEWSKI, G., & CRAWFORD, L. (1986) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1986.tb09919.x · Cited by 495
Self-citationIdentification of a novel p53 functional domain that is necessary for efficient growth suppression
Walker, K. K., & Levine, A. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.26.15335 · Cited by 471
The mechanism and functions of ATP‐dependent proteases in bacterial and animal cells
GOLDBERG, A. L. (1992) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1992.tb19822.x · Cited by 450
Analysis of genomic sequences of 95 papillomavirus types: uniting typing, phylogeny, and taxonomy
Chan, S. Y., Delius, H., Halpern, A. L., & Bernard, H. U. (1995) · Journal of Virology · doi:10.1128/jvi.69.5.3074-3083.1995 · Cited by 411
Snijders, P. J. F., van den Brule, A. J. C., Schrijnemakers, H. F. J., Snow, G., Meijer, C. J. L. M., & Walboomers, J. M. M. (1990) · Journal of General Virology · doi:10.1099/0022-1317-71-1-173 · Cited by 404
Is p53 Polymorphism Maintained by Natural Selection?
Beckman, G., Birgander, R., Själander, A., Saha, N., Holmberg, P. Å., Kivelä, A., & Beckman, L. (1994) · Human Heredity · doi:10.1159/000154228 · Cited by 362
Berkhout, R. J. M., Tieben, L. M., Smits, H. L., Bavinck, J. N. B., Vermeer, B. J., & ter Schegget, J. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.3.690-695.1995 · Cited by 336
The polyproline region of p53 is required to activate apoptosis but not growth arrest
Sakamuro, D., Sabbatini, P., White, E., & Prendergast, G. C. (1997) · Oncogene · doi:10.1038/sj.onc.1201263 · Cited by 316
CANCER, WARTS, AND SUNSHINE IN RENAL TRANSPLANT PATIENTS
Boyle, J., Briggs, J. D., Mackie, R., Junor, B. J. R., & Aitchison, T. C. (1984) · The Lancet · doi:10.1016/s0140-6736(84)92221-9 · Cited by 295
p53 point mutation in HPV negative human cervical carcinoma cell lines.
Crook, T., Wrede, C. D., & Vousden, K. H. (1991) · PubMed · Cited by 272
The Role of Papillomaviruses in Human Anogenital Cancer
zur Hausen, H., & Schneider, A. (1987) · The Papovaviridae · doi:10.1007/978-1-4757-0584-3_9 · Cited by 265
Androphy, E. J., Hubbert, N. L., Schiller, J. T., & Lowy, D. R. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb04849.x · Cited by 233
Li, X., & Coffino, P. (1996) · Journal of Virology · doi:10.1128/jvi.70.7.4509-4516.1996 · Cited by 201
Absence of p53 gene mutations in primary neuroblastomas.
Vogan, K. J., Bernstein, M. L., Leclerc, J., Brisson, L., Brossard, J., Brodeur, G. M., Pelletier, J., & Gros, P. (1993) · PubMed · Cited by 196
Shamanin, V. A., Glover, M., Rausch, C., Proby, C. M., Leigh, I. M., Hausen, H. Z., & de Villiers, E. M. (1994) · PubMed · Cited by 175
Self-citationFunctional p53 protein in human papillomavirus-positive cancer cells.
Butz, K., Shahabeddin, L., Geisen, C., Spitkovsky, D., Ullmann, A., & Hoppe‐Seyler, F. (1995) · PubMed · Cited by 146
Higher lung cancer risk for younger African-Americans with the Pro/Pro p53 genotype
Jin, X., Wu, X., Roth, J. A., Amos, C. I., King, T. M., Branch, C. D., Honn, S. E., & Spitz, M. R. (1995) · Carcinogenesis · doi:10.1093/carcin/16.9.2205 · Cited by 143
Determination of the allelic frequencies of an L-myc and a p53 polymorphism in human lung cancer
Weston, A., Cawley, H., Caporaso, N. E., Bowman, E. D., Hoover, R. N., Trump, B. F., & Harris, C. C. (1994) · Carcinogenesis · doi:10.1093/carcin/15.4.583 · Cited by 92
Marston, N., Crook, T., & Vousden, K. H. (1994) · PubMed · Cited by 69
Sakamoto, H., Lewis, M. S., Kodama, H., Appella, E., & Sakaguchi, K. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.19.8974 · Cited by 53
A novel p53 germline alteration identified in a late onset breast cancer kindred.
Sun, X. F., Jóhannsson, Ó. Þ., Håkansson, S., et al. (1996) · PubMed · Cited by 35
Polymorphism at codon 72 of the p53 gene in human acute myelogenous leukemia
Zhang, W., Hu, G., & Deisseroth, A. (1992) · Gene · doi:10.1016/0378-1119(92)90738-b · Cited by 32
Medcalf, E. A., & Milner, J. (1993) · PubMed · Cited by 31
Norrsell, H., Bengtsson, J., Jovall, P., & Hansson, G. C. (1992) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1992.tb19858.x · Cited by 7
(1995) · PubMed
Cited by
The causal relation between human papillomavirus and cervical cancer
Bosch, F. X., Lorincz, A., Munoz, N., Meijer, C. J. L. M., & Shah, K. V. (2002) · Journal of Clinical Pathology · doi:10.1136/jcp.55.4.244 · Cited by 3,538
TP53 mutations in human cancers: origins, consequences, and clinical use.
Olivier, M., Hollstein, M., & Hainaut, P. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a001008 · Cited by 2,199
Skin cancers after organ transplantation
Euvrard, S., Kanitakis, J., & Claudy, A. (2003) · New England Journal of Medicine · doi:10.1056/nejmra022137 · Cited by 1,575
The ubiquitin-proteasome pathway: on protein death and cell life
Ciechanover, A. (1998) · The EMBO Journal · doi:10.1093/emboj/17.24.7151 · Cited by 1,426
Papillomaviruses Causing Cancer: Evasion From Host-Cell Control in Early Events in Carcinogenesis
Hausen, H. Z. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.9.690 · Cited by 1,298
Metadata
- Authors
- Storey, A., Thomas, M., Kalita, A., Harwood, C., Gardiol, D., Mantovani, F., Breuer, J., Leigh, I. M., Matlashewski, G., & Banks, L.
- Venue
- Nature
- Published
- 1998-05
- Volume
- 393
- Issue
- 6682
- Pages
- 229-234
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1643155728
- Cited by
- 974
- References
- 37
- FWCI
- 25.60
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.